Key HIV Care Teams Let Go, Putting Mothers and Children at Risk
By I. Edwards HealthDay Reporter
WEDNESDAY, April 9, 2025 -- The Trump administration has let go of the last remaining U.S. health officials who oversaw HIV care for more than 1.1 million mothers and children in low-income countries.
The move raises alarms about how these vulnerable groups will get care.
The officials — who worked in multiple U.S. agencies, including the Centers for Disease Control and Prevention (CDC), State Department and the U.S. Agency for International Development (USAID) — managed programs funded through the President’s Emergency Plan For AIDS Relief (PEPFAR).
These efforts help prevent HIV transmission from mothers to babies and treat children who are already infected. But those teams were eliminated last week during an abrupt reorganization.
“We hope this is not a sign that treating mothers and children is no longer important in PEPFAR, and that this is a mistake that can be corrected,” a federal health official who asked not to be named, told The New York Times.
Though PEPFAR funding still exists, there’s now a shortage of staff to run the programs, The Times said.
It’s unclear how the money will be used without the experts who oversaw 300 grants across more than 40 countries.
"We were totally blindsided that the whole unit at CDC is being terminated," said Dr. Anja Giphart, executive vice president of medical and scientific affairs at the Elizabeth Glaser Pediatric AIDS Foundation.
Her group relies on the CDC for 60% of its funding and only has money promised through September.
According to a study published Tuesday in The Lancet, cutting off PEPFAR support could lead to 1 million new HIV infections and nearly 500,000 AIDS-related deaths in children by 2030.
In places like sub-Saharan Africa, one child under age 15 dies from AIDS every seven minutes, The Times reported.
What's more, pregnant women with HIV often get treatment at prenatal clinics, which lowers the risk of infecting their babies from 1 in 3 to less than 1%, according to National Institutes of Health data.
CDC staff had been helping countries plan for new HIV drug deliveries and tracking medicine shortages caused by the January foreign aid freeze. Now, that coordination has disappeared.
“This coordination is especially critical right now because we’re in a period of immense change,” the anonymous CDC official said.
"Time is of the essence,” Giphart agreed. “That seems to not really be taken into consideration with all these changes that are being made.”
Sources
- The New York Times, April 8, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
HIV Drug, Lamivudine, Potentially Effective Against Diabetic Eye Disease
FRIDAY, June 20, 2025 — A cheap HIV drug might be able to help people with diabetes reverse a complication that can lead to blindness, a new small-scale study says. The...
Mean Age of Moms at First Birth Increased From 2016 to 2023
MONDAY, June 16, 2025 -- From 2016 to 2023, there was an increase in the mean age of mothers at first birth and at higher-order births, according to the June 13 National Vital...
Bugaboo Recalls 18,000+ Giraffe High Chairs Due to Fall Risk
MONDAY, June 16, 2025 — Parents, take note: Bugaboo is recalling more than 18,000 of its Giraffe high chairs following reports of the legs separating from the frame. The...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.